Steven Cohen Haleon PLC Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$8.01 - $8.64 $4.97 Million - $5.36 Million	-620,371 Reduced 66.48%	312,829 $2.58 Million
Q1 2024 May 15, 2024	BUY	$8.02 - $8.67 $7.48 Million - $8.09 Million	933,200 New	933,200 $7.92 Million
Q3 2023 Nov 14, 2023	BUY	$7.85 - $8.94 $3.96 Million - $4.51 Million	504,500 Added 2009.96%	529,600 $4.41 Million
Q2 2023 Aug 14, 2023	SELL	$8.04 - $9.0 $3.01 Million - $3.37 Million	-374,400 Reduced 93.72%	25,100 $210,000
Q1 2023 May 15, 2023	SELL	$7.57 - $8.37 $14.5 Million - $16.1 Million	-1,917,692 Reduced 82.76%	399,500 $3.25 Million
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.06 $13.8 Million - $18.7 Million	2,317,192 New	2,317,192 $18.5 Million

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.